title: Hemoptysis caused by saphenous vein graft perforation during percutaneous coronary intervention.
abstract: Percutaneous coronary intervention carries the risk of coronary artery perforation, which may lead to serious adverse effects such as cardiac tamponade, myocardial infarction, and even death. We describe a patient who developed hemoptysis immediately after saphenous vein graft rupture, which is a rare complication during coronary intervention. Stenting using a covered stent, along with simultaneous administration of protamine, helped seal the vein graft perforation and stop the hemoptysis.
authors.affiliation: Second Section of Cardiology, Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
authors.forename: Dong-Yi
authors.initials: DY
authors.lastname: Chen
authors.forename: Chun-Chi
authors.initials: CC
authors.lastname: Chen
authors.forename: I-Chang
authors.initials: IC
authors.lastname: Hsieh
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006469:Hemoptysis / Q000209:etiology*; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011479:Protamines / Q000627:therapeutic use; D012421:Rupture / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D012501:Saphenous Vein / Q000293:injuries* / Q000637:transplantation; D015607:Stents; D057772:Vascular System Injuries / Q000188:drug therapy / Q000628:therapy*
chemical_list: D006494:Heparin Antagonists; D011479:Protamines